Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Molecular Therapy(2021)10.1016/j.ymthe.2021.06.004Source: DataRank Database

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 282 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access282 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (42)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Dorottya Laczkó ORCID,Hamna Shahnawaz ORCID,Hiromi Muramatsu ORCID,Ambika Natesan,Amir Yadegari ORCID

Live enrichment

PubMed:34091054 PMC:PMC8571164

National Institutes of Health

Grant: AI124429

National Institutes of Health

Grant: HL134839

National Institutes of Health

Grant: P30-AI-045008

NIAID NIH HHS

Grant: R01 AI124429

NIAID NIH HHS

Grant: P30 AI045008

NHLBI NIH HHS

Grant: R01 HL134839

National Institutes of Health

Grant: 5P30AI045008-10

Core--Immunology Facility

hybridLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S1525001621003105/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001621003105?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001621003105?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8571164

Europe_PMChttps://europepmc.org/articles/PMC8571164

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Lymph NodesSpleenCD4-Positive T-LymphocytesAnimalsMice, Inbred C57BLHumansMiceLipidsRNA, MessengerImmunotherapyTransfectionRecombination, GeneticNanoparticlesCOVID-19SARS-CoV-2COVID-19 Vaccines

Keywords

Genetic recombinationmRNAT cellLipid NanoparticleLnpTargeted Mrna DeliveryCD4-Positive T-LymphocytesRecombination, GeneticCOVID-19 VaccinesSARS-CoV-2COVID-19TransfectionLipidsMice, Inbred C57BLMiceAnimalsHumansNanoparticlesOriginal ArticleImmunotherapyLymph NodesRNA, MessengerSpleen

Sustainable Development Goals

SDG 3: 3. Good health